Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2025-05-06 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
关于使用闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a disclosure announcement from Shanghai Boxun Medical Biological Instruments Co., Ltd. regarding the progress of using idle proprietary funds to purchase financial products. It includes details about the amounts, types, and terms of financial products purchased, risk control measures, and compliance with disclosure rules. The document is relatively short (4360 characters) and focuses on a specific financing activity involving the company's own funds and financial products. It is not a full financial report, audit report, or earnings release, nor is it a management or board change announcement. It is an update on capital usage and financing activities, specifically the use of idle funds for investment in financial products. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-05-06 Chinese
2024年年度报告业绩说明会预告公告
AGM Information Classification · 95% confidence The document is a notice announcing a scheduled performance explanation meeting related to the company's 2024 Annual Report. It references the already published 2024 Annual Report (announcement number 2025-018) and provides details about the upcoming meeting for investors to discuss the report. The document is short (1103 characters) and does not contain the actual annual report or financial data, but rather announces the event to discuss the report. According to the 'Menu vs Meal' rule, this is an announcement about a report-related event, not the report itself. Therefore, the appropriate classification is AGM Information (AGM-R), as it relates to materials shared during an annual general meeting or similar shareholder meeting event.
2025-04-27 Chinese
第四届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the meeting date, attendance, and the approval of the company's 2025 first quarter report. The document references the actual quarterly report (2025 first quarter report) which is disclosed separately on the Beijing Stock Exchange information platform (announcement number 2025-040). The current document itself does not contain the financial data or the report but is an announcement of the meeting resolution approving the report. Given the document length (953 characters) and content, it fits the category of a Regulatory Filing (RNS) as it is a formal announcement related to regulatory compliance and meeting resolutions, not the report itself.
2025-04-27 Chinese
第四届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the sixth meeting of the fourth board of directors of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the meeting's convening, attendance, and the approval of the company's 2025 first quarter report. The document explicitly states that the 2025 first quarter report itself is disclosed separately on the Beijing Stock Exchange information disclosure platform (announcement number 2025-040). This document does not contain the actual quarterly financial data or substantive financial analysis but rather announces the board's approval of the report. The document length is short (1082 characters) and serves as a meeting resolution announcement rather than the report itself. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2025-04-27 Chinese
2025年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2025 年第一季度报告" which translates to "2025 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the period January to March 2025. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It is unaudited, which is common for interim reports. There are no indications that this is an announcement of a report or a certification document. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-04-27 Chinese
关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's use of idle raised funds for cash management, including details of the amounts, products, counterparties, and risk disclosures. It is a regulatory disclosure about financing activities related to the use of raised capital, not a full financial report or earnings release. The document length is under 5,000 characters and it provides detailed information about capital usage and compliance with stock exchange rules. This fits the category of Capital/Financing Update (CAP).
2025-04-20 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.